Anthracycline Extravasation Injuries: Management With Dexrazoxane

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s3694
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Pharmacological and Clinical Profile of Dexrazoxane (SAVENE® Intravenous Infusion 500 Mg), a Therapeutic Agent for Anthracycline Extravasation

Folia Pharmacologica Japonica
Pharmacology
2015English

Painless Skin Erythema in a Patient With a Chemoport: Anthracycline Therapy Extravasation Presenting With Skin Necrosis

The Southwest Respiratory and Critical Care Chronicles
2014English

Use of Allogeneic Platelet Gel in the Management of Chemotherapy Extravasation Injuries: A Case Report

OncoTargets and Therapy
OncologyPharmacology
2015English

Evaluation of the Cost-Effectiveness of Dexrazoxane for the Prevention of Anthracycline-Related Cardiotoxicity in Children With Sarcoma and Haematologic Malignancies: A European Perspective

Cost Effectiveness and Resource Allocation
Health Policy
2020English

Management of Patients With Forearm and Hand Injuries

International Surgery Journal
2020English

Extravasation Injury With Nonionic Contrast Material.

American Journal of Roentgenology
MedicineNuclear MedicineRadiologyImaging
1993English

Management of Head Injuries

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1983English

Management of Head Injuries

Journal of the Royal Society of Medicine
Medicine
1986English

Initial Management of Injuries

BMJ
1962English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy